These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15989660)
1. Approaches to antibacterial drug discovery. Chopra I Expert Opin Investig Drugs; 1997 Aug; 6(8):1019-24. PubMed ID: 15989660 [TBL] [Abstract][Full Text] [Related]
2. High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery. Ayon NJ Metabolites; 2023 May; 13(5):. PubMed ID: 37233666 [TBL] [Abstract][Full Text] [Related]
3. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
4. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I. Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT J BUON; 2016; 21(4):764-779. PubMed ID: 27685895 [TBL] [Abstract][Full Text] [Related]
5. Postgenomic strategies in antibacterial drug discovery. Brötz-Oesterhelt H; Sass P Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314 [TBL] [Abstract][Full Text] [Related]
6. Optimization of antibacterial cyclic decapeptides. Qin C; Bu X; Zhong X; Ng NL; Guo Z J Comb Chem; 2004; 6(3):398-406. PubMed ID: 15132600 [TBL] [Abstract][Full Text] [Related]
7. QSAR classification model for antibacterial compounds and its use in virtual screening. Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546 [TBL] [Abstract][Full Text] [Related]
9. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509 [TBL] [Abstract][Full Text] [Related]
10. Application of combinatorial library methods in cancer research and drug discovery. Lam KS Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108 [TBL] [Abstract][Full Text] [Related]
11. Recent developments in antibacterial drug discovery: microbe-derived natural products--from collection to the clinic. Leeds JA; Schmitt EK; Krastel P Expert Opin Investig Drugs; 2006 Mar; 15(3):211-26. PubMed ID: 16503759 [TBL] [Abstract][Full Text] [Related]
12. The Evolution of DNA-Templated Synthesis as a Tool for Materials Discovery. O'Reilly RK; Turberfield AJ; Wilks TR Acc Chem Res; 2017 Oct; 50(10):2496-2509. PubMed ID: 28915003 [TBL] [Abstract][Full Text] [Related]
13. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. Pucci MJ Drugs R D; 2007; 8(4):201-12. PubMed ID: 17596107 [TBL] [Abstract][Full Text] [Related]
14. Phage display for target-based antibacterial drug discovery. Christensen DJ; Gottlin EB; Benson RE; Hamilton PT Drug Discov Today; 2001 Jul; 6(14):721-727. PubMed ID: 11445463 [TBL] [Abstract][Full Text] [Related]
15. Bacterial DNA replication enzymes as targets for antibacterial drug discovery. Sanyal G; Doig P Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504 [TBL] [Abstract][Full Text] [Related]
17. When will the genomics investment pay off for antibacterial discovery? Mills SD Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281 [TBL] [Abstract][Full Text] [Related]
18. Application of SBDD to the discovery of new antibacterial drugs. Finn J Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458 [TBL] [Abstract][Full Text] [Related]
19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]